SUPPORTI G MATERIALS A D METHODS

Synthesis
Reactions were conducted under an atmosphere of nitrogen when anhydrous solvents were used. All reactions were monitored by thin-layer chromatography (TLC) using silica plates with fluorescence indicator (SiO 2 -60, F-254) visualising under UV light and by spraying with 5% conc. sulphuric acid in absolute ethanol (v/v) followed by heating. All reagents were obtained from commercial suppliers and were used without further purification. Petroleum ether of the distillation range 60-80 °C was used. The silica gel (0.040-0.063 mm) used for column chromatography was purchased from Merck. After drying of organic phases, filtration was performed. The percentages indicated for the constituents of the solvent mixtures used for silica gel column chromatography refer to volume ratios. After silica gel column chromatography, fractions containing product were pooled, evaporated under reduced pressure, and dried overnight under high vacuum (oil pump) to give the product unless otherwise specified. Chemical shifts are given in ppm relative to tetramethylsilane or the deuterated solvent as internal standard for 1 H NMR and 13 C NMR, and relative to 85% H 3 PO 4 as external standard for 31 P NMR. Scalar coupling constants are given in Hz. For rotameric mixtures only chemical shift values for the major rotamer are given. MALDI-HRMS were recorded in positive ion mode on an IonSpec Fourier transform mass spectrometer. The composition of the oligonucleotides was verified by MALDI-MS on a Micromass Tof Spec E mass spectrometer using a matrix of diammonium citrate and 2,6-dihydroxyacetophenone. (2) . Nucleoside 1(1) (500 mg, 0.72 mmol) was dissolved in a mixture of anhydrous CH 2 Cl 2 (20 mL) and anhydrous pyridine (5 mL). The mixture was cooled to 0 °C and triflouromethanesulfonic anhydride (0.2 mL, 1.4 mmol) was slowly added. The mixture was stirred for 2 h while reaching rt and was then diluted with dichloromethane (75 mL) and washed with saturated aqueous NaHCO 3 (3x50 mL). The organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was dissolved in a mixture of anhydrous THF (20 mL) andmethylpiperazine (0.1 mL, 9.0 mmol). The mixture was stirred at rt for 6 days after which the mixture was evaporated to dryness and purified by column chromatography using 0.5-4.0% half saturated methanolic ammonia in CH 2 Cl 2 . This gave nucleoside 2 as an white solid (316 mg, 40%). 1 5'-O-(4,4'-Dimethoxytrityl)-4'-C-(N-methylpiperazinomethyl)thymidine (3). Nucleoside 2 (150 mg, 0.19 mmol) was dissolved in anhydrous THF (10 mL), and a solution of tetrabutylamonium fluoride solution in THF (1M, 0.25 mL, 0.25 mmol) was added. The mixture was stirred at rt for 4 h and then evaporated to dryness under reduced pressure. The residue was purified by dry vacuum column chromatography using 0-13% methanol in ethyl acetate as the eluent. This gave nucleoside 3 as a white solid (98 mg, 76%). 1 (4) . Nucleoside 3 (200 mg, 0.30 mmol) was dissolved in anhydrous CH 2 Cl 2 (5 mL) together with , -diisopropylethylamine (0.15 mL, 0.86 mmol) and 2cyanoethyl , -(diisopropyl)phosphoramidochloridite (0.08 mL, 0.40 mmol) was added to the solution. After 24 h the mixture was diluted with CH 2 Cl 2 (50 mL) and washed with saturated aqueous NaHCO 3 (3x50 mL). The organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified using column chromatography using 0.5% triethylamine and 0-5% methanol in CH 2 Cl 2 affording nucleoside 3 as a white solid (164 mg, 63%). 31 P-NMR ((CD 3 ) 2 SO) δ154.8, 154.6.
3'-O-tert-Butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-4'-C-(N-methylpiperazinomethyl)thymidine
3'-O-Cyanoethoxy
(diispropylamino)phosphino-5'-O-(4,4'-dimethoxytrityl)-4'-C-((N- methylpiperazino)methyl)thymidine
3'-O-tert-Butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-4'-C-(piperazinomethyl)thymidine (5).
Nucleoside 1(1) (2.0 g, 2.90 mmol) was dissolved in a mixture of anhydrous CH 2 Cl 2 (16 mL) and anhydrous pyridine (4 mL). The mixture was cooled to 0 ºC and trifluoromethanesulfonic anhydride (Tf 2 O, 0.60 mL, 3.63 mmol) was added slowly. After stirring for 2 h at rt, CH 2 Cl 2 (100 mL) was added and the mixture was washed with a saturated aqueous solution of NaHCO 3 (3 x 50 mL). The organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was dissolved in anhydrous THF (50 mL) and piperazine (700 mg, 8.13 mmol) was added. The mixture was heated to 50 ºC, stirred for 20 h, cooled to rt and finally evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 1-6% halfsaturated methanolic ammonia in CH 2 Cl 2 ) as eluent yielding nucleoside 5 (1.22 g, 1.59 mmol, 54%) as white solid. 1 3'-O-tert-Butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-4'-C-(N-(fluorenylmethylcarbonyl)piperazinomethyl)thymidine (6). Nucleoside 5 (1.22 g, 1.58 mmol) was dissolved in anhydrous pyridine (30 mL) and 9-fluorenylmethyl chloroformate (FmocCl, 563 mg, 2.18 mmol) was added. After stirring at rt for 1 h, the mixture was evaporated to dryness under reduced pressure, and the residue was coevaporated with anhydrous acetonitrile. The residue was purified by silica gel column chromatography using 0.5% pyridine in CH 2 Cl 2 as eluent yielding nucleoside 6 (1.51 g, 98%) as a white solid. 1 
5'-O-(4,4'-Dimethoxytrityl)-4'-C-(N-(fluorenylmethylcarbonyl)piperazinomethyl)thymidine (7).
Nucleoside 6 (1.51 g, 1.55 mmol) was dissolved in anhydrous THF (80 mL) and triethylamine trishydrofluoride (4.5 mL, 27.6 mmol) was added together with pyridine hydrochloride (2.00 g, 17.31 mmol). After stirring at rt for 7 h, CH 2 Cl 2 (250 mL) was added and the mixture was washed with a saturated aqueous solution of NaHCO 3 (3x100 mL). The separated organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 0.5% pyridine in CH 2 Cl 2 as eluent yielding nucleoside 7 (941 mg, 70%) as a white solid. 1 
3'-O-Cyanoethoxy(diispropylamino)phosphino-5'-O-(4,4'-dimethoxytrityl)-4'-C-(N-(fluorenylmethylcarbonyl)piperazinomethyl)thymidine (8).
Nucleoside 7 (425 mg, 0.49 mmol) was dissolved in anhydrous CH 2 Cl 2 (10 mL) and , -diisopropylethylamine (0.25 mL) was added. 2-Cyanoethyl , -(diisopropyl)phosphoramidochloridite (0.13 mL, 0.52 mmol) was added slowly. After stirring at rt for 2 h, the mixture was evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 50-60% ethyl acetate and 0.5% triethylamine in n-heptane as eluent yielding amidite 8 (287 mg, 54%) as a white solid. 31 
Nucleoside 5 (300 mg, 0.39 mmol) was dissolved in anhydrous CH 2 Cl 2 (6 mL) and 1-pyrenecarboxylic acid (170 mg, 0.69 mmol) was added followed by 1,1'-carbonyldiimidazole (120 mg, 0.74 mmol). After stirring for 3 h at rt, CH 2 Cl 2 (50 mL) was added and the resulting mixture was washed with a saturated aqueous solution of NaHCO 3 (3x20 mL). The organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified by column chromatography eluting with 0.5% pyridine in CH 2 Cl 2 yielding nucleoside 9a (288 mg, 75%, rotameric mixture) as a white solid. 1 
5'-O-(4,4'-Dimethoxytrityl)-4'-C-(N-(pyren-1-ylcarbonyl)piperazinomethyl)thymidine (10a).
Nucleoside 9a (275 mg, 0.28 mmol) was dissolved in anhydrous THF (7 mL) and tetrabutylammonium fluoride (1M solution in THF, 0.45 mL, 0.45 mmol) was added. After stirring for 16 h at rt, ethyl acetate (50 mL) was added and the resulting mixture was washed with a saturated aqueous solution of NaHCO 3 (3x30 mL). The separated organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified by column chromatography using 0.5% pyridine in CH 2 Cl 2 as eluent yielding nucleoside 10a (200 mg, 82%, rotameric mixture) as a white solid. 1 
. Nucleoside 10a (200 mg, 0.23 mmol) was coevaporated with acetonitrile (2x7 mL) and dissolved in a stirred mixture of anhydrous CH 2 Cl 2 (7 mL) and , -diisopropylethylamine (0.15 mL, 0.86 mmol) at rt. 2-Cyanoethyl , -(diisopropyl)phosphoramidochloridite (0.10 mL, 0.45 mmol) was added slowly, and after 5 h the mixture was evaporated to dryness under reduced pressure. The residue was purified by column chromatography using 50-60% ethyl acetate containing 0.5% triethylamine in n-heptane as eluent yielding amidite 11a (163 mg, 67%) as a white solid. 31 P NMR ((CD 3 ) 2 SO) δ 150.08, 149.85.
3-O-tert-Butyldimethylsilyl-5'-O-(4,4'-dimethoxytrityl)-4'-C-(N-(pyren-1ylbutanoyl)piperazinomethyl)thymidine (9b).
Nucleoside 5 (300 mg, 0.39 mmol) was dissolved in anhydrous CH 2 Cl 2 (6 mL) and 1-pyrenebutyric acid (170 mg, 0.59 mmol) was added together with 1,1'-carbonyldiimidazole (120 mg, 0.74 mmol). After stirring for 1 h at rt, CH 2 Cl 2 (50 mL) was added and the resulting mixture was washed with a saturated aqueous solution of NaHCO 3 (3x30 mL). The separated organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 0-1.5% MeOH and 0.5% pyridine in CH 2 Cl 2 as eluent yielding nucleoside 9b (302 mg, 74%, rotameric mixture) as a white solid. 1 
5'-O-(4,4'-Dimethoxytrityl)-4'-C-(N-(pyren-1-ylbutanoyl)piperazinomethyl)thymidine (10b).
Nucleoside 9b (290 mg, 0.282 mmol) was dissolved in anhydrous THF (7 mL) and tetrabutylammonium fluoride (1M solution in THF, 0.45 mL, 0.45 mmol) was added. After stirring for 16 h, ethyl acetate (50 mL) was added and the resulting mixture was washed with a saturated aqueous solution of NaHCO 3 (3x30 mL). The separated organic phase was dried (Na 2 SO 4 ) and evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 0.5% pyridine in CH 2 Cl 2 as eluent yielding nucleoside 10b (207 mg, 80%, rotameric mixture) as a white solid material. 1 
3'-O-Cyanoethoxy(diispropylamino)phosphino-5'-O-(4,4'-dimethoxytrityl)-4'-C-(N-(pyren-1ylbutanoyl)piperazinomethyl)thymidine (11b).
Nucleoside 10b (200 mg, 0.22 mmol) was dissolved under stirring at rt in anhydrous CH 2 Cl 2 (7 mL) and , -diisopropylethylamine (0.15 mL, 0.86 mmol) was added. 2-Cyanoethyl , -(diisopropyl)phosphoramidochloridite (0.10 mL, 0.42 mmol) was added slowly, and after 2 h the mixture was evaporated to dryness under reduced pressure. The residue was purified by silica gel column chromatography using 50-60% ethyl acetate and 0.5% triethylamine in n-heptane as eluent yielding amidite 11b (157 mg, 64%) as a white solid. 31 P NMR ((CD 3 ) 2 SO δ 149.89, 149.68.
General procedure for oligonucleotide conjugation. The oligonucleotide to be conjugated was synthesised using ordinary phosphoramidite coupling conditions on an automated DNA synthesiser without use of a final detritylation step to leave the 5'-end DMT-protected. The syntheses were performed in 1 µmol scale using polystyrene as the solid support. The support was transferred from the reaction column to an eppendorf tube and treated with 20% piperidine in DMF (1 mL) for 20 min. The supernatant was aspired with a syringe with a small needle and the support was washed with acetonitrile (4x1 mL). The support was then suspended in anhydrous DMF (1 mL) and divided into three approximately even sized portions in three eppendorf tubes. A mixture of 1pyrenecarboxylic acid or 1-pyrenebutyric acid (15 µmol), O-(benzotriazol-1-yl)-, , ′, ′tetramethyluronium hexafluorophosphate (3.7 mg, 9.5 µmol), and , -diisopropylethylamine (10 µl, 5.7 µmol) in DMF (1 mL) was added to each eppendorf tube which was vortexed gently for 45 min. The supernatant was then aspired using a syringe with a small needle and the support was washed with DMF (2x1 mL) and MeOH (2x1 mL). The oligonucleotide was released from the solid support by treatment with saturated aqueous ammonia for 24 h at rt which also removed the protecting groups on the nucleobases. The O5'-DMT-protected oligonucleotide was subsequently purified by reversed phase HPLC whereupon the O5'-DMT group was cleaved off by treatment with 80% AcOH (100 µl) for 20 min followed by addition of sodium acetate (3M, 50 µl), water (100 µl) and ethanol (600 µl). The solution was cooled to -18 ˚C for 1 h. The precipitated oligonucleotide was then isolated after centrifuging at 5 ˚C by decanting of the supernatant. The conjugated oligonucleotide was desalted on a NAP-column using standard procedure. Yields were estimated assuming that each solution in one eppendorf tube contained 0.33 µmol of the parent unconjugted oligonucleotide. Modified oligonucleotides (O 2-O 4, O 6, O 8, O 21, O 22, O 24, O 25 and O 27-O 31) .
Oligonucleotides were synthesised in 1 µmol scale by the phosphoramidite approach using standard conditions on an automated DNA synthesiser. The coupling yields were >90% for modified phosphoramidites (10 min coupling time, 1H-tetrazole as activator) and ≈99% for unmodified DNA phosphoramidites (2 min coupling time, 1H-tetrazole as activator). Deprotection was performed using saturated aqueous ammonia (10 h, 55 °C). The O5'-DMT-protected oligonucleotides were purified by reversed phase HPLC on a C-18 column. The O5'-DMT group was cleaved off by treatment with 80% AcOH (100 µl) for 20 min followed by addition of sodium acetate (3M, 50 µl), water (100 µl) and ethanol (600 µl). The solution was cooled to -18 ˚C for 1 h. The precipitated oligonucleotide was then isolated after centrifuging at 5 ˚C by decanting of the supernatant. The composition of all oligonucleotides was verified by MALDI-MS analysis and the purity of (>80%) by capillary gel electrophoresis. v/v acetonitril. The alifatic proton chemical shifts are derived from a NOESY spectrum without acetonitril.
Figure S1. The aromatic to H1' region of the 200 ms NOESY spectrum of the pip:DNA duplex. The sequential H1'(n-1) -H6/8(n)for the modified strand and unbroken line for the DNA strand.
-17 -
The aromatic to H1' region of the 200 ms NOESY spectrum of the pip:DNA duplex. H1'(n) connectivity pathways are indicated with a broken line for the modified strand and unbroken line for the DNA strand.
The aromatic to H1' region of the 200 ms NOESY spectrum of the pip:DNA duplex.
H1'(n) connectivity pathways are indicated with a broken line 
